RESEARCH-USE BIOSIMILAR ANTIBODY
Rafivirumab
Monoclonal antibody · IgG1
Rafivirumab (CR57) is an anti-rabies virus monoclonal antibody for the prophylaxis of rabies. Rafivirumab has neutralizing potency against a broad spectrum of RABV variants. Rafivirumab can be used for research of cocktails.
TARGETRV Antigenic Site III
YMonoclonal antibody
CATALOGSC-BS-245
CATALOG NUMBERSC-BS-245
MOLECULAR WEIGHTApprox. 145.76 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Rafivirumab (CR57) is an anti-rabies virus monoclonal antibody for the prophylaxis of rabies. Rafivirumab has neutralizing potency against a broad spectrum of RABV variants. Rafivirumab can be used for research of cocktails.
Rafivirumab is a recombinant research-use antibody directed against RV Antigenic Site III.